Results for tag: "Hypoplastic Left Heart Syndrome Drug"

Hypoplastic Left Heart Syndrome (HLHS) is a rare congenital heart defect in which the left side of the heart is underdeveloped. This condition requires a series of surgeries to correct, and is often treated with a combination of drugs and medical devices. Cardiovascular drugs used to treat HLHS include diuretics, anti-arrhythmic drugs, and vasodilators. Diuretics are used to reduce fluid buildup in the lungs, while anti-arrhythmic drugs are used to regulate the heart rate. Vasodilators are used to reduce the workload on the heart by widening the blood vessels. The HLHS drug market is a specialized segment of the larger cardiovascular drug market. It is composed of pharmaceutical companies that develop and manufacture drugs specifically for the treatment of HLHS. Companies in this market include Pfizer, Merck, and Novartis, as well as smaller, specialized companies such as CardioKinetix and CardioCell. Show Less Read more